Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
35.53
-0.74 (-2.04%)
At close: Nov 28, 2025, 1:00 PM EST
36.27
+0.74 (2.08%)
After-hours: Nov 28, 2025, 4:11 PM EST
Azenta Revenue
In the fiscal year ending September 30, 2025, Azenta had annual revenue of $593.82M, down -9.52%. Azenta had revenue of $159.19M in the quarter ending September 30, 2025, a decrease of -6.39%.
Revenue (ttm)
$593.82M
Revenue Growth
-9.52%
P/S Ratio
2.74
Revenue / Employee
$179,946
Employees
3,300
Market Cap
1.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 593.82M | -62.50M | -9.52% |
| Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
| Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
| Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
| Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
AZTA News
- 9 days ago - Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 - PRNewsWire
- 18 days ago - Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast - PRNewsWire
- 26 days ago - Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer - PRNewsWire
- 6 weeks ago - Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana - PRNewsWire
- 4 months ago - Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Azenta (AZTA) Q3 EPS Jumps 36% - The Motley Fool
- 4 months ago - Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance - PRNewsWire